Copyright
©The Author(s) 2022.
World J Clin Oncol. Nov 24, 2022; 13(11): 880-895
Published online Nov 24, 2022. doi: 10.5306/wjco.v13.i11.880
Published online Nov 24, 2022. doi: 10.5306/wjco.v13.i11.880
Figure 7 Phototherapeutic effects of photodynamic therapy on KB xenografts and body weight in mice.
A: Tumor volume change is expressed as the relative tumor volume (volume on the indicated day/starting volume prior to the treatment. Tumors-treated by near-infrared photodynamic therapy (NIR-PDT) (50 J/cm2), irradiation alone (50 J/cm2), folate-Si-rhodamine-1 alone, and no treatment are shown in pink (○), gray (■), orange (●), and blue (□), respectively. Tumors-treated by NIR-PDT show significantly delayed growth compared to those of other groups. Values represent the mean ± SD (n = 8), aP < 0.05 NIR-PDT vs other groups; B: Average body weight did not differ significantly among the four groups of mice; C: Images of ex vivo tumors excised 16 d after treatment. FolateSiR-1: Folate-Si-rhodamine-1; NIR-PDT: Near-infrared photodynamic therapy; IR: Laser irradiation; CTR: Control.
- Citation: Aung W, Tsuji AB, Hanaoka K, Higashi T. Folate receptor-targeted near-infrared photodynamic therapy for folate receptor-overexpressing tumors. World J Clin Oncol 2022; 13(11): 880-895
- URL: https://www.wjgnet.com/2218-4333/full/v13/i11/880.htm
- DOI: https://dx.doi.org/10.5306/wjco.v13.i11.880